Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0759
D

Medication Administration Errors Exceeding Acceptable Rate

Philadelphia, Pennsylvania Survey Completed on 02-10-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to maintain a medication error rate below five percent, as evidenced by the administration errors involving Resident R51. On February 5, 2025, a Licensed Nurse, identified as Employee E5, administered Memantine 5 mg in tablet form after crushing it, contrary to the physician's order which specified Memantine HCL, ER 7 mg Capsule to be given whole. The nurse confirmed the medication as Memantine 5 mg tab, which was incorrect according to the resident's prescribed treatment plan. The literature review indicated that enteric-coated medications like Memantine ER should not be crushed, highlighting a significant deviation from proper medication administration protocols. Additionally, the same nurse administered Ferrous Sulfate 325 mg RED Type in a crushed form, despite the physician's order to administer it as a whole tablet. The literature review supported that Ferrous Sulfate tablets should not be crushed, further contributing to the medication error rate. These errors were confirmed by the Director of Nursing during an interview, resulting in a calculated medication error rate of 7.14%, which exceeds the regulatory threshold of five percent.

Plan Of Correction

1. R51's medication orders were reviewed and clarified by the physician including the addition of an order that licensed staff may crush crushable medications on 2/10/2025. R51 experienced no ill effects from this event. E5 was re-educated on the "Medication Administration Policy" and the "Do Not Crush" listing. 2. The Director of Nursing or designee will conduct an audit on current residents' medication orders to ensure that residents have an order, if applicable, that licensed staff may crush crushable medications by 2/28/25. The Director of Nursing or designee will audit the medication pass of current residents to ensure compliance with physicians' medication orders and that only applicable medications are being crushed by 2/28/25. 3. The Director of Nursing or designee will provide re-education to current licensed staff on the "Medication Administration Policy" and the "Do Not Crush" listing including the requirement to adhere to the orders of the prescriber by 3/10/25. 4. The Director of Nursing or designee will complete a random audit on the medication pass of 5 residents to ensure compliance with physicians' medication orders and that only applicable medications are being crushed weekly for 4 weeks and then monthly for 2 months. The results of these audits will be forwarded to the Quality Assurance Process Improvement team for review and recommendations.

An unhandled error has occurred. Reload 🗙